022dkk
-24,1 %
Date:2025-10-10Time:18:00:00Latest report:Q1-2025List:SpotlightTicker:DANCAN
Market Cap:1 mdkkEnterprise Value:0 mdkkNet Sales:7,31 mdkkEarnings:-8,09 mdkkEmployees:0ISIN:DK0063631999

Ratios

10-year key figure history for Dancann Pharma turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for Dancann Pharma with index and moving average MA50 and MA200.

Stockprice:0,22
MA50:0,77
MA200:1,38
Price/MA200:-84,0 %
RSI (14):25,2
Price/MA50:-71,6 %

Description

DanCann Pharma is a Danish pharmaceutical company focused on the discovery, development, manufacture and commercialization of medical cannabis and cannabinoid-based pharmaceuticals. The company manufactures and distributes prescription and over-the-counter pharmaceuticals, primarily focused on pain patients for the treatment of chronic diseases and pain conditions. DanCann Pharma was founded in 2018 and is headquartered in Denmark.

Pharmaceuticals